Furthermore, TRPV4 antagonists have shown therapeutic potential in experiment animal models for a range of conditions, including heart failure, edema, pain, gastrointestinal disorders, lung diseases, and various cancers [57]. Here, TRPV4 is linked to digestive system disorder.